306 related articles for article (PubMed ID: 24841915)
1. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model.
Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ
Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915
[TBL] [Abstract][Full Text] [Related]
2. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
Waissbluth S; Salehi P; He X; Daniel SJ
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
[No Abstract] [Full Text] [Related]
4. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model.
Yüksel Aslıer NG; Tağaç AA; Durankaya SM; Çalışır M; Ersoy N; Kırkım G; Yurdakoç K; Bağrıyanık HA; Yılmaz O; Sütay S; Güneri EA
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336
[TBL] [Abstract][Full Text] [Related]
6. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
[TBL] [Abstract][Full Text] [Related]
7. The Sustained-Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Cisplatin-Induced Hearing Loss.
Fernandez R; Harrop-Jones A; Wang X; Dellamary L; LeBel C; Piu F
Audiol Neurootol; 2016; 21(1):22-9. PubMed ID: 26789647
[TBL] [Abstract][Full Text] [Related]
8. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
Schweitzer VG
Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis.
Kohn S; Fradis M; Pratt H; Zidan J; Podoshin L; Robinson E; Nir I
Laryngoscope; 1988 Aug; 98(8 Pt 1):865-71. PubMed ID: 3398664
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
Hill GW; Morest DK; Parham K
Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
[TBL] [Abstract][Full Text] [Related]
13. Curcuma longa (curcumin) decreases in vivo cisplatin-induced ototoxicity through heme oxygenase-1 induction.
Fetoni AR; Eramo SL; Paciello F; Rolesi R; Podda MV; Troiani D; Paludetti G
Otol Neurotol; 2014 Jun; 35(5):e169-77. PubMed ID: 24608370
[TBL] [Abstract][Full Text] [Related]
14. Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study.
Liu Y; Jolly C; Braun S; Janssen T; Scherer E; Steinhoff J; Ebenhoch H; Lohner A; Stark T; Kiefer J
Hear Res; 2015 Sep; 327():89-101. PubMed ID: 25987502
[TBL] [Abstract][Full Text] [Related]
15. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
16. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of Salvia miltiorrhiza on gentamicin-induced ototoxicity.
Shi L; An Y; Wang A; Gao Q; Yang Y
Am J Otolaryngol; 2014; 35(2):171-9. PubMed ID: 24119490
[TBL] [Abstract][Full Text] [Related]
18. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
20. The role of extended preoperative steroids in hearing preservation cochlear implantation.
Kuthubutheen J; Coates H; Rowsell C; Nedzelski J; Chen JM; Lin V
Hear Res; 2015 Sep; 327():257-64. PubMed ID: 26117408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]